Modernizing the Diagnosis and Treatment of Gender Dysphoria: A Neurobiologically Grounded Policy Framework is a white paper authored by Joseph Ben-Simon (Bensimon Labs), offering a scientifically rigorous model for determining eligibility for irreversible gender-affirming medical interventions. Grounded in current research across neuroimaging, developmental neuroscience, and medical ethics, the framework proposes objective diagnostic criteria based on neurodevelopmental maturity, longitudinal brain morphology, and multidisciplinary review. It distinguishes between supportive care and irreversible procedures, with an emphasis on clinical integrity and institutional safeguards. The document provides policy leaders, insurance providers, and medical boards with actionable recommendations to align transgender health protocols with established standards in public health, bioethics, and pediatric medicine. It is designed to inform legislation, coverage policy, and clinical governance in the treatment of gender dysphoria. 🔄 Update (May 15, 2025) – Appendix 1 Now Included in Official Extended Release 📎 Appendix 1 – Clinical Criteria for Diagnostic Oversight and Treatment Deferment is now officially released and attached to the core framework in this extended version. This release represents a composite institutional edition of the white paper, combining the original framework (v1.21) with Appendix 1 (CDOTD v1.0). The appendix establishes the clinical, ethical, and legal criteria for diagnostic deferment and is foundational to the interpretation of all subsequent appendices. The combined document extends full copyright protection from the original framework to all attached material and should be cited as: Ben-Simon, J. (2025). Modernizing the Diagnosis and Treatment of Gender Dysphoria: A Neurobiologically Grounded Policy Framework — Extended Release with Appendix 1 (v1.21 + CDOTD v1.0). Bensimon Labs. https://doi.org/10.5281/zenodo.15098234 🛡️ Distribution class: Institutional and Legal Review Only📅 Appendix 1 release date: May 15, 2025📚 Appendix DOI inheritance: Framework v1.21 DOI retained for unified citation Update (April 15, 2025) Appendix 1 – Clinical Criteria for Diagnostic Oversight and Treatment Deferment is scheduled for formal release on May 15, 2025. Update (April 14, 2025) – GitHub Repository Now Live: Future appendices and framework updates will be published on GitHub and automatically archived on Zenodo for citation and institutional access.Legacy updates to the original white paper will continue to be maintained manually at:🔗 https://zenodo.org/records/15172424 🔗 https://github.com/bensimonlabs/gender-dysphoria-policy-framework Update (April 10, 2025) – Feedback Mechanism Now Live:Professionals and institutional reviewers may now submit fully anonymous feedback on the proposed neurobiological diagnostic framework for gender dysphoria. No names, emails, or tracking data is collected. 🔗 Submit feedback here: https://www.bensimonlabs.com/npp Privacy Verification: https://themarkup.org/blacklight Update (April 4, 2025) : A series of formal appendices will be added after the initial 30-day expert review period, incorporating insights from early institutional feedback and expert commentary. These appendices will expand on the legal, ethical, clinical, and accessibility dimensions of the proposed framework — including: Case law and precedent for legal defensibility Insurance-linked accessibility models (including federally subsidized MRI sequences) Neurological justification for diagnostic gatekeeping A public communication strategy grounded in medical ethics and science translation Morphometric Diagnostic Audit for comparative Thresholds for Neurostructural, Morphometric, and Morphometric-Neuropsychiatric Conditions Across Developmental Stages Each appendix will be version-linked and publicly released on Zenodo. The appendices have been structured as discrete modules to support domain-specific expert review; selected sections may be consolidated following the comment period to facilitate integrated institutional analysis across legal, clinical, and diagnostic domains. 🔄 Version 1.2 — Contact Update 📬 Updated contact email for direct policy feedback and institutional review:GDFPolicyFeedback@bensimonlabs.com No changes to framework content, clinical recommendations, or citations. 🔄 Version 1.21 — Minor Correction ✅ Removed a single duplicate reference from the bibliography to ensure citation integrity. 📚 Added full reference list to the Zenodo “Reference string” metadata field to support indexing, citation parsing, and institutional compliance. Registered with the U.S. Copyright Office (2025) and linked to the author's ORCID:https://orcid.org/0009-0003-2959-5271